Nihal Sinha is a Partner at F-Prime Capital based in the London office and focuses primarily on biotech and healthcare IT in Europe.

At F-Prime Nihal has been involved in a number of cell and gene therapy investments including as a member of the founding team of Orchard Therapeutics.

Prior to joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals. Nihal holds a MB BChir with distinction from the University of Cambridge and is a Member of the Royal College of Physicians.